DENVER, April 12 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc., (OTC:GLOB) (BULLETIN BOARD: GLOB) announced today that it has signed an agreement with the University of North Carolina Hospitals (UNC Hospitals) to provide its SafeTrace(R) donor management system. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Located in Chapel Hill, UNC Hospitals is already a user of Wyndgate's transfusion management software solution, SafeTrace Tx(R)*. With its purchase of SafeTrace, it is now Wyndgate's newest Vein-to-Vein(R) client. Once the donor management system is installed, it will interface seamlessly with the medical center's SafeTrace Tx system to allow complete blood donation tracking from collection through laboratory testing and final transfusion. SafeTrace will also assist the hospital with pre-collection capabilities such as donor recruitment and scheduling. Laura McClannan, Assistant Administrative Director for Transfusion Medicine at UNC Hospitals, stated, "Our staff selected Wyndgate's SafeTrace donor management system for its ability to offer comprehensive safety features and to fully integrate our donor and transfusion services. SafeTrace can help UNC Hospitals grow our donor program and alleviate concerns about the capability of our operations to keep up with that growth. We believe that the future of Wyndgate and UNC Hospitals mirror each other -- both positive. Considering our experience with SafeTrace Tx, adding Wyndgate's SafeTrace solution was the wise choice." Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, said, "We are very pleased to announce this agreement with such a prestigious medical center as UNC Hospitals. UNC Hospitals saw the value of the implementation experience Wyndgate provided during the installation of our transfusion solution, SafeTrace Tx. UNC Hospitals' installation of Wyndgate's donor management software clearly demonstrates Wyndgate's commitment to the growing hospital blood donation center market." About the University of North Carolina Health Care System The UNC Health Care System is a not-for-profit integrated health care system owned by the state of North Carolina. UNC Health Care is made up of UNC Hospitals -- including N.C. Memorial Hospital, N.C. Children's Hospital, N.C. Women's Hospital, N.C. Neurosciences Hospital and the N.C. Jaycee Burn Center -- and is associated with the University of North Carolina at Chapel Hill School of Medicine. This network allows the system to move the results of biomedical research from medical school laboratories to patient care settings. For more information, visit their website at http://www.unchealthcare.org/. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc., +1-303-238-2000; or Investor Relations, Paul Short, President of Investment Strategies, LLC, +1-304-523-3252, for Global Med Technologies, Inc. Web site: http://www.unchealthcare.org/ Web site: http://www.globalmedtech.com/ http://www.wyndgate.com/

Copyright